Few excuses really seem to fit other than the clothing retailer forgot who its customer was.
Deriving 95% of its sales from advertising should help fuel its stock price for years to come.
M&A is a big part of Pfizer's growth strategy, but the company hasn't done a very good job of reasonably pricing its purchases.
The company needs something to boost it out of its also-ran status in wearable tech, and a medical-grade device might help.
Billionaire investors Warren Buffett, George Soros, and Carl Icahn recently made these big bets.
Buy them cheap and hold them for the rest of time.
The leading online retailer is reportedly about to make a big splash in digital music, but a half-priced offering may be all washed up.
The company changed credit cards and while the road was bumpy, it navigated it well.
Retirees may want to consider adding shares of Cisco Systems, Bank of America, and Pfizer to their portfolios right now. Here's why.
The spread between WTI and Brent can have a dramatic impact on shale-producer profitability.